4.7 Article

Multimodal neuroimaging in post-COVID syndrome and correlation with cognition

Journal

BRAIN
Volume 146, Issue 5, Pages 2142-2152

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/awac384

Keywords

post-COVID syndrome; cognitive impairment; functional connectivity; grey matter; white matter

Ask authors/readers for more resources

Diez-Cirarda et al. report persistent structural and functional brain alterations 11 months after acute SARS-CoV-2 infection, which are associated with cognitive dysfunction and contribute to a better understanding of the pathophysiology of the post-COVID syndrome.
Diez-Cirarda et al. report persistent structural and functional brain alterations, in cortical and subcortical structures, 11 months after acute SARS-CoV-2 infection. The changes were associated with cognitive dysfunction, and suggest several pathophysiological mechanisms relevant to post-COVID syndrome. Brain changes have been reported in the first weeks after SARS-CoV-2 infection. However, limited literature exists about brain alterations in post-COVID syndrome, a condition increasingly associated with cognitive impairment. The present study aimed to evaluate brain functional and structural alterations in patients with post-COVID syndrome, and assess whether these brain alterations were related to cognitive dysfunction. Eighty-six patients with post-COVID syndrome and 36 healthy controls were recruited and underwent neuroimaging acquisition and a comprehensive neuropsychological assessment. Cognitive and neuroimaging examinations were performed 11 months after the first symptoms of SARS-CoV-2. Whole-brain functional connectivity analysis was performed. Voxel-based morphometry was performed to evaluate grey matter volume, and diffusion tensor imaging was carried out to analyse white-matter alterations. Correlations between cognition and brain changes were conducted and Bonferroni corrected. Post-COVID syndrome patients presented with functional connectivity changes, characterized by hypoconnectivity between left and right parahippocampal areas, and between bilateral orbitofrontal and cerebellar areas compared to controls. These alterations were accompanied by reduced grey matter volume in cortical, limbic and cerebellar areas, and alterations in white matter axial and mean diffusivity. Grey matter volume loss showed significant associations with cognitive dysfunction. These cognitive and brain alterations were more pronounced in hospitalized patients compared to non-hospitalized patients. No associations with vaccination status were found. The present study shows persistent structural and functional brain abnormalities 11 months after the acute infection. These changes are associated with cognitive dysfunction and contribute to a better understanding of the pathophysiology of the post-COVID syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Biochemistry & Molecular Biology

Predominance of visuoconstructive impairment after mild COVID-19?

Maria Diez-Cirarda, Miguel Yus, Jorge Matias-Guiu, Jordi A. Matias-Guiu

MOLECULAR PSYCHIATRY (2023)

Article Cardiac & Cardiovascular Systems

Coronary microvascular dysfunction is associated with impaired cognitive function: the cerebral-coronary connection study (C3 study)

Hernan Mejia-Renteria, Alejandro Travieso, Jordi A. Matias-Guiu, Miguel Yus, Carolina Espejo-Paeres, Francesca Finocchiaro, Sara Fernandez, Carlos Ignacio Gomez-Escalonilla, Blanca Reneses-Prieto, Maria Dulcenombre Gomez-Garre, Alfonso Delgado-Alvarez, Ana Bustos, Leopoldo Perez de Isla, Jose Juan Gomez de Diego, Javier Modrego-Martin, Adriana Ortega-Hernandez, Petros Papadopoulos, Juan Arrazola-Garcia, Jorge Matias-Guiu, Javier Escaned

Summary: This study reveals the correlation between coronary microcirculatory dysfunction in patients with coronary artery disease (CAD) and cerebral small vessel disease (CSVD), as well as cognitive impairment.

EUROPEAN HEART JOURNAL (2023)

Article Neurosciences

Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis

Alfonso Delgado-Alvarez, Maria Diez-Cirarda, Cristina Delgado-Alonso, Laura Hernandez-Lorenzo, Constanza Cuevas, Maria Valles-Salgado, Paloma Montero-Escribano, Maria Jose Gil-Moreno, Jorge Matias-Guiu, Rocio Garcia-Ramos, Jordi A. Matias-Guiu

Summary: The study validated the effectiveness of the Rowland Universal Dementia Assessment Scale (RUDAS) in patients with Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). The results showed that RUDAS performed well in diagnosing cognitive impairment associated with AD, PD, and MS, with minimal influence from education and cultural biases.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Clinical Neurology

Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson's disease

Maria Diez-Cirarda, Alberto Cabrera-Zubizarreta, Ane Murueta-Goyena, Antonio P. Strafella, Rocio Del Pino, Marian Acera, Olaia Lucas-Jimenez, Naroa Ibarretxe-Bilbao, Beatriz Tijero, Juan Carlos Gomez-Esteban, Inigo Gabilondo

Summary: Visual hallucinations (VH) are present in up to 75% of Parkinson's disease (PD) patients. However, their neural bases and participation of the visual system in VH are not well-understood in PD. This study found specific functional and structural abnormalities within the visual system in PD patients with VH, which could potentially serve as biomarkers for VH in PD.

JOURNAL OF NEUROLOGY (2023)

Correction Clinical Neurology

Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson's disease (Nov, 10.1007/s00415-022-11427-x, 2022)

Maria Diez-Cirarda, Alberto Cabrera-Zubizarreta, Ane Murueta-Goyena, Antonio P. Strafella, Rocio Del Pino, Marian Acera, Olaia Lucas-Jimenez, Naroa Ibarretxe-Bilbao, Beatriz Tijero, Juan Carlos Gomez-Esteban, Inigo Gabilondo

JOURNAL OF NEUROLOGY (2023)

Editorial Material Geriatrics & Gerontology

Editorial: Current advances in genetic presentations of dementia and aging, volume II

Yuzhen Xu, Ulises Gomez-Pinedo, Jun Liu, Daojun Hong, Jun Xu

FRONTIERS IN AGING NEUROSCIENCE (2023)

Article Cell Biology

In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies

Ulises Gomez-Pinedo, Jordi A. Matias-Guiu, Denise Ojeda-Hernandez, Sarah de la Fuente-Martin, Ola Mohamed-Fathy Kamal, Maria Soledad Benito-Martin, Belen Selma-Calvo, Paloma Montero-Escribano, Jorge Matias-Guiu

Summary: The implantation of oligodendrocyte precursor cells is a potential therapeutic strategy for remyelination. However, it is unclear how these cells behave after implantation and if they retain the ability to proliferate and differentiate into myelin-forming oligodendrocytes. This study evaluates the impact of corticosteroids on cell proliferation, differentiation, and survival, finding that corticosteroids reduce these capacities and do not support remyelination.

CELLS (2023)

Article Clinical Neurology

Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study

Silvia Oliver-Mas, Cristina Delgado-Alonso, Alfonso Delgado-Alvarez, Maria Diez-Cirarda, Constanza Cuevas, Lucia Fernandez-Romero, Andreu Matias-Guiu, Maria Valles-Salgado, Lidia Gil-Martinez, Maria Jose Gil-Moreno, Miguel Yus, Jorge Matias-Guiu, Jordi A. Matias-Guiu

Summary: In a study, Oliver-Mas et al. found that anodal transcranial direct current stimulation on the left prefrontal dorsolateral cortex improved physical fatigue in patients with post-COVID syndrome. The treatment had no adverse effects and showed a statistically significant improvement in physical fatigue compared to the sham stimulation. However, no significant effect was observed on cognitive fatigue or quality of life. Further studies are needed to confirm these findings and optimize stimulation protocols.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms

Cristina Delgado-Alonso, Maria Diez-Cirarda, Josue Pagan, Carlos Perez-Izquierdo, Silvia Oliver-Mas, Lucia Fernandez-Romero, Alvaro Martinez-Petit, Maria Valles-Salgado, Maria Jose Gil-Moreno, Miguel Yus, Jorge Matias-Guiu, Jose Luis Ayala, Jordi A. Matias-Guiu

Summary: Brain fog associated with COVID-19 is characterized by attention and episodic memory symptoms, and fatigue serves as the main mediator between objective and subjective cognition. Our findings contribute to understanding the pathophysiology of brain fog and underline the importance of unraveling the main mechanisms underlying brain fog, taking into account multiple aspects.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Medicine, General & Internal

Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome

Maria Diez-Cirarda, Miguel Yus-Fuertes, Rafael Sanchez-Sanchez, Javier J. Gonzalez-Rosa, Gabriel Gonzalez-Escamilla, Lidia Gil-Martinez, Cristina Delgado-Alonso, Maria Jose Gil-Moreno, Maria Valles-Salgado, Fatima Cano-Cano, Denise Ojeda-Hernandez, Natividad Gomez-Ruiz, Silvia Oliver-Mas, Maria Soledad Benito-Martin, Manuela Jorquera, Sarah de la Fuente, Carmen Polidura, Belen Selma-Calvo, Juan Arrazola, Jorge Matias-Guiu, Ulises Gomez-Pinedo, Jordi A. Matias-Guiu

Summary: Cognitive deficits are a major symptom in both COVID-19 patients and post-COVID syndrome (PCS). The hippocampus, a key region for cognition, shows vulnerability to SARS-CoV-2 infection. In PCS patients, hippocampal grey matter atrophy, altered microstructural integrity, hypoperfusion, and functional connectivity changes are observed. Blood biomarkers, such as GFAP, MOG, CCL11, and NfL, show alterations in PCS and are associated with hippocampal volume changes.

EBIOMEDICINE (2023)

No Data Available